Forward Science Technologies' oral cancer screening device, OralID, will be available in Europe this fall.
The company has acquired the CE Mark for OralID and is negotiating with several international distributors to distribute the device around the world, Forward Science announced.
With cases of oral cancer continuing to rise, OralID is positioned to enhance the early discovery of oral cancer worldwide, the company noted.
Forward Science first joined with Maxdent, a company founded to support the early detection of oral cancer, based in the Netherlands. This month, Maxdent will offer the OralID in the Netherlands, Belgium, Luxemburg, Lithuania, and Latvia.